UK-election Breaker M

UK Defence Stocks: Does Defence Spending Review Herald Further Upside?

Neil Wilson
Neil Wilson

Investor Content Strategist




Key Points:

  • UK Defence Review targets £68bn increase in military budget
  • British armed forces need major investment to become ‘war-ready’
  • UK defence stocks are likely to be the main winners from increased spend
This content is marketing material. This article is not investment advice, capital is at risk.

Regime shifts happen seldom, but we are seeing a strategic realignment of gigantic proportions in terms of European defence spending and posturing. The UK has just released its latest defence review, calling for major investment in key technologies and weapons to make Britain ‘war ready’. It ‘s all part of what many analysts are calling a structural rather than cyclical shift; a European defence supercycle.

Defence Secretary John Healey said "we are in a new era of threat, which demands a new era for UK defence", while outlining his defence spending plans. The UK needs "stronger deterrents" to avoid the huge costs, human and economic, that wars create, he told MPs in the Commons.

The review suggests the UK will need to spend about £68bn to prepare the armed forces for modern warfighting. The government had already pledged to increase the defence budget to 2.5% of GDP by 2027, but the prime minister did not give a precise date for when UK defence spending would hit 3% of GDP. Nato wants members to hit 3.5% as it faces up to rising threats from Russia.

In addition to boosting spending on cyber threats and drones, it also outlines the need for big ticket items such as new fighter jets, attack submarines and nuclear warheads, which could lead to major contract wins for a number of the UK’s largest defence firms.

Stocks Affected

The standout from the review among the services is the Navy, with the government pledging to boost the fleet of nuclear-powered attack submarines from seven to 12. It calls for up to 12 new attack boats developed by the UK’s Aukus partnership with the US and Australia by the late 2030s, part of a strategic shift focused on defending home waters.

BAE Systems, which builds submarines for the Royal Navy, including the Astute nuclear-powered attack class, is among the most obvious names to benefit. Shares have rallied since the announcement. The company also manufactures about four-fifths of the munitions for the armed forces and is likely to benefit from plans to build six new munitions factories in the UK.

Rolls-Royce is another that is exposed to the submarine supply chain as it builds the nuclear reactors that drive the engines. It recently reported interim results that hailed it hitting mid-term targets two years early.

Babcock, which maintains and services all of the UK’s boats, rose sharply on Monday after the announcement on submarines.

Other UK names to consider include military technology businesses Chemring and Qinetiq, as well as aerospace component maker Senior and respiratory protection specialist Avon Technologies. Among these, Chemring has just reported a record order book. The tailwinds are evident but it’s unclear whether the best of the running is already behind us.

More details about the way the spending review will impact companies directly will be included in the defence industrial strategy, which is expected in the coming weeks.

Looking further afield, Lockheed Martin manufactures the F-35 fighter jet, which the review called for more of. Helsing and Anduril may benefit from more spending on autonomous systems such as drones.

The UK’s defence splurge comes at the same time as a major realignment of European Union spending priorties favouring defence contractors such as Rheinmetall, which is Europe’s biggest munitions manufacturer. The European Commission’s Readiness 2030 programme, which is aimed to accelerate rearmament, could unleash EUR 800bn in spending.

Risks to Consider

A potential ceasefire deal in Ukraine could lead to a short-term reversal in the recent rally, though is unlikely to reduce the perceived threat from Russia.

Consider geographic diversification as US defence names are also getting a boost from the Trump administration with a $150bn one-time injection from the tax bill that is currently going through Congress.

UK defence stocks have had a good run of late – valuations are high relative to the market. According to Panmure Liberum, the sector trades at about a 55% premium to the wider market, vs a 21% discount in 2021. The last six months has clearly been positive for a number of the big names.

 

UK defence names
Source: Saxo

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992